An open-label 16-week study of liraglutide in adolescents with obesity post-sleeve gastrectomy.
Anna ZennoEjike E NwosuSyeda Z FatimaEvan P NadlerNazrat M MirzaSheila M BradySara A TurnerShanna B YangJulia LazarevaJennifer A Te-VasquezKong Y ChenStephanie T ChungJack A YanovskiPublished in: Pediatric obesity (2024)
Liraglutide treatment was feasible and associated with a BMI reduction of 4.3% in adolescents who had previously undergone SG, quantitatively similar to results obtained in adolescents with obesity who have not undergone MBS.